Evidence map›Paper›PMID 21866395›Full record

ArticleJournal of structural and functional genomics2011

A simplified recipe for assigning amide NMR signals using combinatorial 14N amino acid inverse-labeling.

Hidekazu Hiroaki, Yoshitaka Umetsu, Yo-ichi Nabeshima, Minako Hoshi, Daisuke Kohda

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of structural and functional genomics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  6. An optimized NIntrinsically disordered proteins · 2015
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hidekazu HiroakiDivision of Structural Biology, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo, Kobe, 650-0017, Japan. hiroakih@med.kobe-u.ac.jp
Yoshitaka Umetsu
Yo-ichi Nabeshima
Minako Hoshi
Daisuke Kohda

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Assignment of backbone amide proton resonances is one of the most time-consuming stages of any protein NMR study when the protein samples behave non-ideally. A robust and convenient NMR procedure for analyzing spectra of marginal-to-low quality is helpful for high-throughput structure determination. The 14N selective- and inverse-labeling method is a candidate solution. Here, we present a simplified protocol for assigning protein backbone amide NMR signals. When 14N inversely labeled residues are present in a protein, their backbone NH cross peaks vanish from the protein's 1H-(15)N HSQC spectrum, and thus, their chemical shifts can be readily identified by a process of elimination. Some metabolically related amino acids, for example, Ile, Leu, and Val, cannot be individually incorporated but can be inversely labeled together. We optimized and simplified the protocol and M9-based medium formula for the 14N selective- and inverse-labeling method without any additives. Our approach should be cost-effective, because the method could be additively applied stepwise, even when the proteins of interest were found to be non-ideal.

Indexed as

AmidesAmino AcidsAmyloid beta-PeptidesEscherichia coliInterleukin-1betaIsotope LabelingNitrogenNitrogen IsotopesNuclear Magnetic Resonance, BiomolecularPeptide FragmentsPlasmidsProteinsAmidesAmino AcidsAmyloid beta-Peptidesamyloid beta-protein (1-43)Interleukin-1betaNitrogenNitrogen IsotopesPeptide FragmentsProteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.